Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

Quotazioni in diretta

IRWD Ironwood Pharmaceuticals Inc

3,69

-0,03 (-0,81%)

12 Dic 2024 - Chiuso

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares sold to cover taxes from the vesting of stock awards granted by the Issuer.

Date of Notice

11/15/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Andrew Davis

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Ironwood Pharmaceuticals (NASDAQ:IRWD)
Storico
Da Nov 2024 a Dic 2024

Clicca qui per i Grafici di Ironwood Pharmaceuticals

Grafico Azioni Ironwood Pharmaceuticals (NASDAQ:IRWD)
Storico
Da Dic 2023 a Dic 2024

Clicca qui per i Grafici di Ironwood Pharmaceuticals

Notizie Ironwood Pharmaceuticals Inc - IRWD

Form 8-K - Current report
Giovedì 5 Dicembre 2024 (6 giorni fa) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference
Martedì 26 Novembre 2024 (2 settimane fa) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 20 Novembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercoledì 20 Novembre 2024 (3 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 15 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 15 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Giovedì 14 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
Mercoledì 13 Novembre 2024 (4 settimane fa) • Business Wire

Form 8-K - Current report
Martedì 12 Novembre 2024 (4 settimane fa) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Giovedì 7 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 8-K - Current report
Giovedì 7 Novembre 2024 (1 mese fa) • Edgar (US Regulatory)

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
Giovedì 7 Novembre 2024 (1 mese fa) • Business Wire

Più Ironwood Pharmaceuticals Inc Articoli Notizie

Baylin Technologies

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea